<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00410345</url>
  </required_header>
  <id_info>
    <org_study_id>mifepristoneoxytocin-HMO-CTIL</org_study_id>
    <nct_id>NCT00410345</nct_id>
  </id_info>
  <brief_title>Cervical Rippening With Antiprogesterone in Midtrimester Abortions</brief_title>
  <official_title>Cervical Rippening With Antiprogesterone in Midtrimester Abortions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      Induction of midtrimester abortion includes cervical ripening and then contraction to induce
      uterine evacuation. There are several protocols, but most of them include using
      prostaglandins (PG). The disadvantages of using PG include uncomfortable side effects and
      limits of using it for women after cesarean section. Mifepristone is an antiprogesterone drug
      and been used for induction of abortion in first and second trimesters abortions. The aim of
      this study is to explore the effectiveness of Mifepristone for cervical ripening before high
      dose Oxytocin drip.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to explore the effectiveness of Mifepristone for cervical ripening
      before high dose Oxytocin drip in midtrimester abortions. After informed consent, all the
      women will be randomized for Mifepristone or placebo. 48 hours later, high dose oxytocin drip
      will be started and we will examine the success rate to induce abortion, the duration from
      starting oxytocin till evacuation of uterus and side effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success of abortion induction</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>abortion induction duration</measure>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>Abortion, Missed</condition>
  <arm_group>
    <arm_group_label>Pitocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with Pitocin after mifegine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cytotec</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with cytotec after mifegine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mifepristone</intervention_name>
    <arm_group_label>Pitocin</arm_group_label>
    <arm_group_label>Cytotec</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  midtrimester late abortion

          -  midtrimester induced abortion

        Exclusion Criteria:

          -  placenta previa

          -  infected abortion

          -  rupture of membranes

          -  s/p cesarean section *2 or more
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Assaf Ben-Meir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2006</study_first_submitted>
  <study_first_submitted_qc>December 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2006</study_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Missed</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mifepristone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

